MACSF

COMMUNIQUÉS West-GlobeNewswire

UPDATE: Momenta Pharmaceuticals Announces Pricing of Public Offering of Common Stock
07/12/2018
CAMBRIDGE, Mass., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company with a validated scientific platform focused on discovering and developing novel therapeutics to [...]
Viveve Announces Pricing of Public Offering of Shares of Common Stock
07/12/2018
ENGLEWOOD, Colo., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (“Viveve”) (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced the pricing of an underwritten public [...]
Synthorx Announces Pricing of Initial Public Offering
07/12/2018
SAN DIEGO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Synthorx, Inc. (Nasdaq: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics for [...]
Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares
07/12/2018
JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of its previously announced underwritten [...]
New Clinical Data Further Validate SAVI SCOUT® Radar Localization System for Simpler, Positive Axillary Lymph Node Localization
07/12/2018
Poster Presentation at San Antonio Breast Cancer Symposium shows 100% successful wire- free localization with no migration throughout neoadjuvant chemotherapy treatment SAN ANTONIO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- [...]
AEON Global Health Announces Adjournment of Annual Meeting of Shareholders until January 16, 2019
06/12/2018
Annual Meeting adjourned solely with respect to Proposal 4 – approval of an amendment to the Company’s Amended Certificate of Incorporation to continue to restrict certain transfers of its common stock in order to [...]
Canopy Rivers Enhances European Platform With Further Investment in Italy
06/12/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES TORONTO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (the “ Company ” or “ Canopy Rivers ”) (TSXV: RIV) is pleased to announce that it has [...]
Helix Biopharma Corp. Closes First Tranche of Private Placement
06/12/2018
RICHMOND HILL, Ontario, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Globus Medical Enters International Market with ExcelsiusGPS® Robotic Guidance and Navigation System
06/12/2018
First surgeries performed in Greece, Germany, and Italy AUDUBON, Pa., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, recently announced the entrance of [...]
SI-BONE, Inc. Announces Blue Cross Blue Shield of Arizona (BCBS AZ) Establishes Positive Coverage for MIS SI Joint Fusion Exclusively with the Triangular Titanium iFuse Implant System
06/12/2018
BCBS AZ is the 26th U.S. private payer to establish positive exclusive iFuse coverage SANTA CLARA, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- SI-BONE, Inc., a medical device company that pioneered the minimally invasive [...]
The Cooper Companies Announces Fourth Quarter and Full Year 2018 Results
06/12/2018
PLEASANTON, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) today announced financial results for the fiscal fourth quarter and full year ended October 31, 2018. Fourth quarter revenue [...]
Eidos Therapeutics Appoints William Lis to Board of Directors
06/12/2018
SAN FRANCISCO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX), a clinical stage biopharmaceutical company focused on addressing the large unmet need in transthyretin (TTR) amyloidosis ( [...]
Global Blood Therapeutics Announces Proposed Public Offering of Common Stock
06/12/2018
SOUTH SAN FRANCISCO, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (Nasdaq: GBT), a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative [...]
Aeglea BioTherapeutics to Present at BMO Capital Markets 2018 Prescription for Success Healthcare Conference
06/12/2018
Company to Webcast Fireside Chat on Wednesday, December 12 at 3:40 p.m. ET AUSTIN, Texas, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE), a clinical-stage biotechnology company that [...]
Moleculin Announces Conference Call to Discuss FDA Filing and New Immune Checkpoint Data on Wednesday, December 12, 2018
06/12/2018
HOUSTON, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]
Sienna Biopharmaceuticals to Present at BMO Capital Markets Healthcare Conference
06/12/2018
WESTLAKE VILLAGE, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA), a clinical-stage medical dermatology and aesthetics company, today announced that Frederick C. Beddingfield III [...]
Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares
06/12/2018
JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the Company intends to commence an underwritten public [...]
Viveve Announces Positive 12-Month Data from Stress Urinary Incontinence Feasibility Study
06/12/2018
— 72% of women treated experienced an improvement in the one-hour pad weight with an overall mean improvement of 56% — Clinically meaningful benefit achieved at one year across all patient-reported outcome measures — [...]
Viveve Announces Proposed Public Offering of Shares of Common Stock
06/12/2018
ENGLEWOOD, Colo., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (“Viveve”) (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced that it has commenced an underwritten [...]

Pages